Therapeutic management of patients with COVID-19: a systematic review

por Tobaiqy, M., Qashqary, M., Al-Dahery, S., Mujallad, A., Hershan, A.A., Kamal, M.A., Helmi, N.
Publicado 2020

Interaction of Glucagon G-Protein Coupled Receptor with Known Natural Antidiabetic Compounds: Multiscoring In Silico Approach

por Baig, M. H., Ahmad, K., Hasan, Q., Khan, M. K. A., Rao, N. S., Kamal, M. A., Choi, I.
Publicado 2015

Molecular docking and nucleotide sequencing of successive expressed recombinant fungal peroxidase gene in E.coli

por Khedr, Mohamed, Khalil, Kamal M. A., Kabary, Hoda A., Hamed, Ahmed A., Badawy, Mona Shaban E. M., Abu-Elghait, Mohammed
Publicado 2022

Evaluation of propolis, honey, and royal jelly in amelioration of peripheral blood leukocytes and lung inflammation in mouse conalbumin-induced asthma model

por El-Aidy, Waleed K., Ebeid, Ahmad A., Sallam, Abd El-Raouf M., Muhammad, Ibrahim E., Abbas, Ayman T., Kamal, M.A., Sohrab, Sayed Sartaj
Publicado 2015

Drug-independent control strategy of clostridial infection in broiler chickens using anti-toxin environmentally friendly multienzymes

por Saleh, Ahmed A., Hafez, Abdelhaleem, Amber, Khairy, Abdelhady, AbdelRahman Y., Salem, Heba M., Fathy, M., Kamal, M. A., Alagawany, Mahmoud, Alzawqari, Mohammed H.
Publicado 2023

First study of sperm mediated gene transfer in Egyptian river buffalo

por Hassanane, Mohamed S., El Makawy, Aida I., Helalia, Sahar M., Abdoon, Ahmed S., Khalil, Kamal M.A., Ghanem, Tharwat A., Tohamy, Amany M., Sun, Xiao-Feng, Shen, Wei
Publicado 2017

Dupilumab provides favourable long‐term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: results from an open‐label phase IIa stud...

por Cork, M.J., Thaçi, D., Eichenfield, L.F., Arkwright, P.D., Sun, X., Chen, Z., Akinlade, B., Boklage, S., Guillemin, I., Kosloski, M.P., Kamal, M.A., O’Malley, J.T., Patel, N., Graham, N.M.H., Bansal, A.
Publicado 2020

A phase 2, open‐label study of single‐dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy

por Paller, A.S., Siegfried, E.C., Simpson, E.L., Cork, M.J., Lockshin, B., Kosloski, M.P., Kamal, M.A., Davis, J.D., Sun, X., Pirozzi, G., Graham, N.M.H., Gadkari, A., Eckert, L., Ruddy, M., Bansal, A.
Publicado 2020

Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis: results from a phase IIa open‐label trial and subsequent phase III open‐label extension

por Cork, M.J., Thaçi, D., Eichenfield, L.F., Arkwright, P.D., Hultsch, T., Davis, J.D., Zhang, Y., Zhu, X., Chen, Z., Li, M., Ardeleanu, M., Teper, A., Akinlade, B., Gadkari, A., Eckert, L., Kamal, M.A., Ruddy, M., Graham, N.M.H., Pirozzi, G., Stahl, N., DiCioccio, A.T., Bansal, A.
Publicado 2019